Clinical Trials on Plasma Cell Neoplasm in Italy

Total 6840 results

European Institute of Oncology

Recruiting

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

Neuroendocrine Tumors

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant (KRdvsRd)

Multiple Myeloma | New Diagnosis Tumor

Italy
Andres J. M. Ferreri
AGC Biologics S.p.A.

Completed

RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor (INGRID)

Lymphoma, Large B-Cell, Diffuse

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT) (APALITT)

Non-small-cell Lung Cancer

Italy
Rhizen Pharmaceuticals SA

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies (PI3K)

Lymphoma, B-Cell | T-Cell Lymphoma

France, Italy
Regeneron Pharmaceuticals
Sanofi

Terminated

REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer

Non-small Cell Lung Cancer

United States, Italy, Lithuania
Hoffmann-La Roche

Completed

A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Malignant Melanoma

Italy
National Cancer Institute, Naples
AstraZeneca; University of Campania "Luigi Vanvitelli"

Recruiting

A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) (MILES-5)

Carcinoma, Non-Small-Cell Lung

Italy
Sanofi

Completed

ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Italy
Fondazione Melanoma Onlus
Roche S.p.a

Terminated

Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients (VECODUE)

Melanoma | Melanoma (Skin) | Melanoma Stage

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma (Combi G-Vax)

Glioblastoma | Vaccination

Italy
Istituto Oncologico Veneto IRCCS
Azienda Ospedaliera di Padova; Azienda Ospedaliero-Universitaria Careggi, Firenze

Recruiting

An Integrated Radio-immunological Approach (IMMUNO-IMAGING)

Glioma, Malignant

Italy
Eli Lilly and Company

Completed

Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

Non-Small-Cell Lung Cancer

Germany, Italy
Janssen-Cilag Ltd.

Recruiting

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials (REALiTEC/TAL)

Relapsed/Refractory Multiple Myeloma (RRMM)

France, Denmark, Israel, Spain, Italy, Sweden, United Kingdom, Germany
Genzyme, a Sanofi Company

Completed

Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL)

Leukemia, B-Cell, Chronic

Italy
AGC Biologics S.p.A.

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma (NGR007)

Small Cell Lung Cancer

Italy
National Cancer Institute, Naples
Federico II University; University of Campania "Luigi Vanvitelli"

Terminated

Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors (LOTUS)

Neuroendocrine Tumors

Italy
Pfizer
Pierre Fabre Laboratories

Terminated

Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma

Melanoma

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Autoimmune Hemolytic Anemia | Monoclonal B-Cell Lymphocytosis CLL-Type

Italy
Genentech, Inc.
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma (CAMMA 1)

Multiple Myeloma

Korea, Republic of, United States, Denmark, Italy, Spain, France, Japan, Israel, United Kingdom, Poland, Australia, Canada, Czechia
AbbVie

Active, not recruiting

Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, France, Germany, Italy, Japan, Spain
Leiden University Medical Center
Boehringer Ingelheim; Chordoma Foundation

Active, not recruiting

Afatinib in Locally Advanced and Metastatic Chordoma

Chordoma

United Kingdom, Netherlands, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Bladder Cancer

Italy
European Organisation for Research and Treatment...

Terminated

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Bladder Cancer

Italy
Southern Europe New Drug Organization
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Unknown

Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)

Lymphoma, Mantle-Cell

Italy
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Stage II Multiple Myeloma | Stage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditions

United States, Germany, Italy
Francesco De Cobelli

Recruiting

Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms

Kidney Cancer | Renal Cell Carcinoma | Liver Cancer | Liver Metastasis Colon Cancer

Italy
IRCCS San Raffaele

Recruiting

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer (ITHORinVHL)

Clear Cell Renal Cell Carcinoma | VHL Syndrome

Italy
University of Milano Bicocca

Not yet recruiting

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Malignancies | Glioblastoma, IDH-wildtype | Metformin

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas (itTRIOlym)

Recurrent Disease | DLBCL | MCL

Italy
Regina Elena Cancer Institute
Istituti Fisioterapici Ospitalieri

Recruiting

Biobanking and New Biomolecular Metrics (Melamoma4p)

Melanoma (Skin) | Liquid Biopsy

Italy
Mario Negri Institute for Pharmacological Research
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Humanitas Hospital,...

Recruiting

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone. (TRABEPIO)

Liposarcoma, Myxoid | Liposarcoma, Dedifferentiated | Liposarcoma, Round Cell

Italy
Centro di Riferimento Oncologico - Aviano

Recruiting

Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR) (PULSAR)

Glioma

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Sebaceous Cell Tumor of Eyelid

Italy
ImmunoGen, Inc.

Active, not recruiting

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

Blastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative Neoplasm

United States, Spain, Germany, Italy, France, United Kingdom
AUSL Romagna Rimini
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting

Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment (EXcellenT)

Non-Small Cell Lung Cancer

Italy
Bambino Gesù Hospital and Research Institute

Recruiting

Allogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALL

B-cell Acute Lymphoblastic Leukemia

Italy
Novartis Pharmaceuticals

Completed

Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors

Refractory Desmoplastic Small Round Cell Tumors

Italy
Istituto Oncologico Veneto IRCCS
Janssen Diagnostics, LLC

Unknown

Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors (CMCBRAF)

Metastatic Melanoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
University of Milan; IFOM, The FIRC Institute of Molecular Oncology

Not yet recruiting

FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction (FASTIMMUNE)

Small Cell Lung Carcinoma

Italy
Centro di Riferimento Oncologico - Aviano

Not yet recruiting

Incidence and Characterization of Drivers Oncogenes in the Population With Lung Cancer Afferents to the Cancer Institute in Aviano (IN.ON.D.) (INOND)

Non Small Cell Lung Cancer

Italy
Humanitas Clinical and Research Center

Recruiting

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Renal Cell Carcinoma | Adrenal Carcinoma

Italy
European Institute of Oncology

Recruiting

Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study (MeTe)

Frailty | Neuroendocrine Tumors | Chemotherapy Effect

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto

Not yet recruiting

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL-like MBL | Varicella-zoster Virus Reactivation

Italy
Gruppo Oncologico Italia Meridionale

Unknown

Quality of Life Comparison in Advanced Non-squamous Non Small Cell Lung Cancer (ERACLE)

Non-squamous Nonsmall Cell Neoplasm of Lung

Italy
Galderma R&D

Completed

Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma

Superficial Basal Cell Carcinoma

Finland, Austria, Belgium, France, Italy, Sweden, United Kingdom
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Terminated

Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study) (TOKIO)

Renal Cancer Cell

Italy
Catholic University of the Sacred Heart

Completed

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms (RAPNEN)

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Pancreas Neoplasm | Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting

Italy
Philogen S.p.A.

Completed

Intratumoral Administration of L19IL2/L19TNF

Malignant Melanoma, Skin

Italy
European Institute of Oncology
Merck Sharp & Dohme LLC

Recruiting

ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

Malignant Melanoma

Italy

Clinical Trials on Plasma Cell Neoplasm in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations